This comprehensive session focuses on simplifying type 2 diabetes management through practical insights on DPP-4 inhibitors, with a special emphasis on linagliptin and its role across the disease trajectory. The discussion covers patient selection, renal considerations, cardiovascular safety, long-term glycemic durability, and real-world positioning in diverse clinical scenarios. A clinically oriented update designed to support confident, individualized diabetes care in everyday practice.

Simplifying the Trajectory of T2DM in Current Era: DPP-4i Across the Treatment Landscape

Senior Consultant Nephrologist, Meenakshi Mission Hospital and Research Center, Madurai

Dr. Krishna Swamy Sampathkumar

1

774

16.8k

4.8

Sessions Taken

877

4.8